ClinicalTrials.Veeva
Menu

Find clinical trials for Endometrial Cancer in Rochester, MN

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Ovarian Cancer
Non-Small-Cell Lung Carcinoma
Breast Cancer
Colorectal Cancer
Cancer
Uterine Cervical Cancer
Stomach Cancer

Endometrial Cancer trials near Rochester, MN, USA:

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer (DE-01)

DESTINY-Endometrial01 will investigate the efficacy of first-line T-DXd + rilvegostomig (Arm A) and/or T-DXd+ pembrolizumab (Arm B) when com...

Enrolling
Endometrial Cancer
Drug: Carboplatin
Drug: Paclitaxel

Phase 3

AstraZeneca
AstraZeneca

Rochester, Minnesota, United States and 253 other locations

drug LY3484356 alone or in combination with other anticancer therapies is safe and effective in participants with advanced or metastatic breast cancer...

Active, not recruiting
Endometrial Cancer
Breast Cancer
Drug: Trastuzumab
Drug: Everolimus

Phase 1

Lilly
Lilly

Rochester, Minnesota, United States and 73 other locations

first-in-human study will evaluate the safety, tolerability, pharmacokinetics, and antitumor activity of TORL-1-23 in patients with advanced cancer...

Enrolling
Endometrial Cancer
Ovarian Cancer
Drug: TORL-1-23

Phase 1

TORL Biotherapeutics

Rochester, Minnesota, United States and 13 other locations

-small-cell lung cancer (NSCLC), triple negative breast cancer (TNBC), ovarian cancer (OC), endometrial cancer...

Active, not recruiting
Castration-resistant Prostate Cancer
Lower Esophageal Cancer
Drug: cabozantinib
Drug: atezolizumab

Phase 1

Exelixis
Exelixis

Rochester, Minnesota, United States and 123 other locations

Locations recently updated

can be given alone or with cemiplimab to patients with ovarian cancer or cancer of the uterus* The study will also look at the leve...

Enrolling
Endometrial Cancer
Recurrent Primary Peritoneal Cancer
Drug: Sarilumab
Drug: Ubamatamab

Phase 1, Phase 2

Regeneron Pharmaceuticals
Regeneron Pharmaceuticals

Rochester, Minnesota, United States and 55 other locations

A Study of Emi-Le in Participants with Solid Tumors

Enrolling
Endometrial Cancer
Breast Cancer
Drug: Emi-Le

Phase 1, Phase 2

Day One Biopharmaceuticals

Rochester, Minnesota, United States and 25 other locations

This is a Phase 1/2, open-label, multicenter study evaluating the safety, tolerability, pharmacokinetics, pharmacodynamics and anti-tumor activity of...

Enrolling
Endometrial Cancer
Breast Cancer
Drug: Fulvestrant injection
Drug: TER-2013

Phase 1, Phase 2

Terremoto Biosciences Inc.

Rochester, Minnesota, United States and 19 other locations

This is a two-part, open-label, multicenter, dose escalation and dose expansion study designed to evaluate the safety, tolerability, pharmacokinetics...

Enrolling
Breast Cancer
Epithelial Ovarian Cancer
Drug: ETX-19477

Phase 1, Phase 2

858 Therapeutics, Inc.

Rochester, Minnesota, United States and 13 other locations

This clinical trial is evaluating a drug called ART0380 in participants with advanced or metastatic solid tumors. The main goals of this study are to...

Enrolling
Endometrial Cancer
Metastatic Cancer
Drug: ART0380
Drug: Gemcitabine

Phase 1, Phase 2

Artios Pharma

Rochester, Minnesota, United States and 82 other locations

The proposed study design is a single arm Phase II trial to document the feasibility of carboplatin-mirvetuximab - in patients with advanced-stage EO...

Enrolling
Primary Peritoneal Cancer
Ovarian Cancer
Drug: mirvetuximab soravtansine (MIRV; IMGN853)

Phase 2

The University of Alabama at Birmingham
The University of Alabama at Birmingham

Rochester, Minnesota, United States and 8 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems